References
- Roche E. B. Design of Biopharmaceutical Properties Through Pro-Drugs and Analogs. APHA, Washington, D.C. 1977
- Cooper R. M. Seminars in Oncology 1991; 18(5 suppl. 7)18–29, R. Alexanian, A. Haut, A. U. Khan, M. Lane, E. M. McKelvey, P. H. Migliore, W. J. Stuckey, and H. E. Wilson, JAMA, 208, 1680–1685 (1969)
- Hassner A., Alexanian V. Tet. Lett. 1978; 46: 4475–4478
- Silverstein R. M., Bassler G. C., Morril Spectroscopic T. C. Identification of Organic Compounds, 5th ed. Wiley, New York 1991; 208
- Moroder L., Hallett A., Wunsch E., Keller O., Wersin G. Hoppe Seyler's Z. Physiol. Chem. 1976; 357: 1651–1653
- K-Hsieh H., Marshall G. R. J. Med. Chem. 1981; 28: 1304–1310
- Stahl G. L., Walter R., Smith C. W. J. Organic Chem. 1978; 43: 2285–2286